US Edition
GLP-1 in joint fluid may let weight-loss drugs target arthritis directly
2 Articles
2 Articles
Unexpected Effect of Obesity Drug Could Become an Arthritis Treatment Denmark Aarhus University Research Makes First Discovery of GLP-1 Hormone in Knee Joints A research team at Aarhus University in Denmark has confirmed for the first time that GLP-1, a hormone used in obesity and diabetes treatments, also exists within joints. The academic community believes that this discovery [has long-term effects]
GLP-1 in joint fluid may let weight-loss drugs target arthritis directly
Arthritis includes a range of conditions that affect the joints, from inflammatory diseases such as rheumatoid arthritis and psoriatic arthritis to more common conditions like osteoarthritis. Many people experience pain, stiffness, and a reduced quality of life. Treatment today focuses on reducing inflammation and relieving symptoms, depending on the type of arthritis. However, researchers from the Department of Biomedicine at Aarhus University h
Coverage Details
Bias Distribution
- 50% of the sources are Center, 50% of the sources lean Right
Factuality
To view factuality data please Upgrade to Premium
